Cargando…
Estimating distributions of health state severity for the global burden of disease study
BACKGROUND: Many major causes of disability in the Global Burden of Disease (GBD) study present with a range of severity, and for most causes finding population distributions of severity can be difficult due to issues of sparse data, inconsistent measurement, and need to account for comorbidities. W...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650517/ https://www.ncbi.nlm.nih.gov/pubmed/26582970 http://dx.doi.org/10.1186/s12963-015-0064-y |
_version_ | 1782401505904558080 |
---|---|
author | Burstein, Roy Fleming, Tom Haagsma, Juanita Salomon, Joshua A. Vos, Theo Murray, Christopher JL. |
author_facet | Burstein, Roy Fleming, Tom Haagsma, Juanita Salomon, Joshua A. Vos, Theo Murray, Christopher JL. |
author_sort | Burstein, Roy |
collection | PubMed |
description | BACKGROUND: Many major causes of disability in the Global Burden of Disease (GBD) study present with a range of severity, and for most causes finding population distributions of severity can be difficult due to issues of sparse data, inconsistent measurement, and need to account for comorbidities. We developed an indirect approach to obtain severity distributions empirically from survey data. METHODS: Individual-level data were used from three large population surveys from the US and Australia that included self-reported prevalence of major diseases and injuries as well as generic health status assessments using the 12-Item Short Form Health Survey (SF-12). We developed a mapping function from SF-12 scores to GBD disability weights. Mapped scores for each individual respondent were regressed against the reported diseases and injuries using a mixed-effects model with a logit-transformed response variable. The regression outputs were used to predict comorbidity-corrected health-state weights for the group of individuals with each condition. The distribution of these comorbidity-corrected weights were used to estimate the fraction of individuals with each condition falling into different GBD severity categories, including asymptomatic (implying disability weight of zero). RESULTS: After correcting for comorbid conditions, all causes analyzed had some proportion of the population in the asymptomatic category. For less severe conditions, such as alopecia areata, we estimated that 44.1 % [95 % CI: 38.7 %-49.4 %] were asymptomatic while 28.3 % [26.8 %-29.6 %] of anxiety disorders had asymptomatic cases. For 152 conditions, full distributions of severity were estimated. For anxiety disorders for example, we estimated the mean population proportions in the mild, moderate, and severe states to be 40.9 %, 18.5 %, and 12.3 % respectively. Thirty-seven of the analyzed conditions were used in the GBD 2013 estimates and are reported here. CONCLUSION: There is large heterogeneity in the disabling severity of conditions among individuals. The GBD 2013 approach allows explicit accounting for this heterogeneity in GBD estimates. Existing survey data that have collected health status together with information on the presence of a series of comorbid conditions can be used to fill critical gaps in the information on condition severity while correcting for effects of comorbidity. Our ability to make these estimates may be limited by lack of geographic variation in the data and by the current methodology for disability weights, which implies that severity must be binned rather than expressed in as a full distribution. Future country-specific data collection efforts will be needed to advance this research. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12963-015-0064-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4650517 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46505172015-11-19 Estimating distributions of health state severity for the global burden of disease study Burstein, Roy Fleming, Tom Haagsma, Juanita Salomon, Joshua A. Vos, Theo Murray, Christopher JL. Popul Health Metr Research BACKGROUND: Many major causes of disability in the Global Burden of Disease (GBD) study present with a range of severity, and for most causes finding population distributions of severity can be difficult due to issues of sparse data, inconsistent measurement, and need to account for comorbidities. We developed an indirect approach to obtain severity distributions empirically from survey data. METHODS: Individual-level data were used from three large population surveys from the US and Australia that included self-reported prevalence of major diseases and injuries as well as generic health status assessments using the 12-Item Short Form Health Survey (SF-12). We developed a mapping function from SF-12 scores to GBD disability weights. Mapped scores for each individual respondent were regressed against the reported diseases and injuries using a mixed-effects model with a logit-transformed response variable. The regression outputs were used to predict comorbidity-corrected health-state weights for the group of individuals with each condition. The distribution of these comorbidity-corrected weights were used to estimate the fraction of individuals with each condition falling into different GBD severity categories, including asymptomatic (implying disability weight of zero). RESULTS: After correcting for comorbid conditions, all causes analyzed had some proportion of the population in the asymptomatic category. For less severe conditions, such as alopecia areata, we estimated that 44.1 % [95 % CI: 38.7 %-49.4 %] were asymptomatic while 28.3 % [26.8 %-29.6 %] of anxiety disorders had asymptomatic cases. For 152 conditions, full distributions of severity were estimated. For anxiety disorders for example, we estimated the mean population proportions in the mild, moderate, and severe states to be 40.9 %, 18.5 %, and 12.3 % respectively. Thirty-seven of the analyzed conditions were used in the GBD 2013 estimates and are reported here. CONCLUSION: There is large heterogeneity in the disabling severity of conditions among individuals. The GBD 2013 approach allows explicit accounting for this heterogeneity in GBD estimates. Existing survey data that have collected health status together with information on the presence of a series of comorbid conditions can be used to fill critical gaps in the information on condition severity while correcting for effects of comorbidity. Our ability to make these estimates may be limited by lack of geographic variation in the data and by the current methodology for disability weights, which implies that severity must be binned rather than expressed in as a full distribution. Future country-specific data collection efforts will be needed to advance this research. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12963-015-0064-y) contains supplementary material, which is available to authorized users. BioMed Central 2015-11-18 /pmc/articles/PMC4650517/ /pubmed/26582970 http://dx.doi.org/10.1186/s12963-015-0064-y Text en © Burstein et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Burstein, Roy Fleming, Tom Haagsma, Juanita Salomon, Joshua A. Vos, Theo Murray, Christopher JL. Estimating distributions of health state severity for the global burden of disease study |
title | Estimating distributions of health state severity for the global burden of disease study |
title_full | Estimating distributions of health state severity for the global burden of disease study |
title_fullStr | Estimating distributions of health state severity for the global burden of disease study |
title_full_unstemmed | Estimating distributions of health state severity for the global burden of disease study |
title_short | Estimating distributions of health state severity for the global burden of disease study |
title_sort | estimating distributions of health state severity for the global burden of disease study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650517/ https://www.ncbi.nlm.nih.gov/pubmed/26582970 http://dx.doi.org/10.1186/s12963-015-0064-y |
work_keys_str_mv | AT bursteinroy estimatingdistributionsofhealthstateseverityfortheglobalburdenofdiseasestudy AT flemingtom estimatingdistributionsofhealthstateseverityfortheglobalburdenofdiseasestudy AT haagsmajuanita estimatingdistributionsofhealthstateseverityfortheglobalburdenofdiseasestudy AT salomonjoshuaa estimatingdistributionsofhealthstateseverityfortheglobalburdenofdiseasestudy AT vostheo estimatingdistributionsofhealthstateseverityfortheglobalburdenofdiseasestudy AT murraychristopherjl estimatingdistributionsofhealthstateseverityfortheglobalburdenofdiseasestudy |